Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-011843)

Filing Details

Accession Number:: 0001181431-13-011843
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-02-22 15:59:38
Reporting Period:: 2012-06-01

Filing Date:: 2013-02-22
Accepted Time:: 2013-02-22 15:59:38
Original Submission Date:: 2012-06-06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
822411	Immunocellular Therapeutics Ltd.	IMUC	Pharmaceutical Preparations (2834)	931301885

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1550455	G. James Bender	21900 Burbank Boulevard 3Rd Floor Woodland Hills CA 91304	Vp, Product Development & Mfg.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-06-01	1,500	$3.59	6,179	No	4	S	Direct
Common Stock	Disposition	2012-06-01	4,900	$3.60	1,279	No	4	S	Direct
Common Stock	Disposition	2012-06-01	600	$3.61	679	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

This Form 4 is being amended to correct a calculation error in the Amount of Securities Beneficially Owned Following Reported Transactions.